---
title: "Fimasartan - Hypertension"
sidebar: mydoc_sidebar
permalink: db09279-mesh-d006973-1.html
toc: false 
---


Path ID: `DB09279_MESH_D006973_1`
{% include image.html url="images/db09279-mesh-d006973-1.png" file="db09279-mesh-d006973-1.png" alt="db09279-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C558933">MESH:C558933 </a> | fimasartan | Drug |
| <a href="https://identifiers.org/UniProt:P30556">UniProt:P30556 </a> | Type-1 angiotensin II receptor | Protein |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/GO:0002018">GO:0002018 </a> | renin-angiotensin regulation of aldosterone production | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D000450">MESH:D000450 </a> | Aldosterone | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0032263">HP:0032263 </a> | Increased blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D006973">MESH:D006973 </a> | Hypertension | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fimasartan | DECREASES ACTIVITY OF | Type-1 Angiotensin Ii Receptor |
| Type-1 Angiotensin Ii Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Type-1 Angiotensin Ii Receptor | POSITIVELY REGULATES | Renin-Angiotensin Regulation Of Aldosterone Production |
| Vasoconstriction | CONTRIBUTES TO | Increased Blood Pressure |
| Renin-Angiotensin Regulation Of Aldosterone Production | INCREASES ABUNDANCE OF | Aldosterone |
| Aldosterone | CONTRIBUTES TO | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertension |
|---------|-----------|---------|

Comment: Fimasartan is currently under clinical trial phase III.

Reference: 
  - [https://go.drugbank.com/drugs/DB09279#mechanism-of-action](https://go.drugbank.com/drugs/DB09279#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Fimasartan](https://en.wikipedia.org/wiki/Fimasartan)
  - [https://en.wikipedia.org/wiki/Hypertension](https://en.wikipedia.org/wiki/Hypertension)
